Related Experiment Video
Updated: Feb 6, 2026

Efficient Sporulation of Saccharomyces cerevisiae in a 96 Multiwell Format
Published on: September 17, 2016
Efficient Biosynthesis of Selenium-Enriched Saccharomyces cerevisiae via Siderophore-Assisted selenite uptake and
Wen-Tao Du1, Ya-Ru Wei1, Xue Zhao1
1School of Life Science and Engineering, Key Laboratory of Herbal-Tebitan Drug Screening and Deep Processing of Gansu Province, Lanzhou University of Technology, Lanzhou 730050, China.
Abstract:
Selenium (Se) is essential for health, but its common inorganic forms are toxic, limiting its direct dietary use. This study proposes a siderophore-assisted strategy for producing selenium-enriched Saccharomyces cerevisiae with improved efficiency. The siderophore produced by Aspergillus sp, isolated from iron-rich soil, significantly enhanced S. cerevisiae tolerance to sodium selenite (up to 2000 μg/mL) and increased intracellular Se content to 3.89 mg/g. X-ray Photoelectron Spectroscopy (XPS) and High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) analyses confirmed efficient biotransformation of Se (IV) to organic selenium, primarily selenomethionine (Se-Met), accounting for 97.85% of total selenoamino acids (1201.52 ng/g). The selenium-enriched S. cerevisiae showed potent antioxidant activity, including 2,2-diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radical scavenging rates of 59.85% and 97.18%, respectively. Transcriptomic analysis revealed that Siderophore-mediated selenium transport is not fully dependent on the high-affinity phosphate transporters and may involve the participation of Pho91p. This study offers a feasible strategy for producing selenium-enriched S. cerevisiae and a promising approach for bioavailable organic selenium supplements.
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Biosynthesis in Bacteria
Biosynthesis of Polysaccharides
Biosynthesis of Lipids
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

